Melanoma Genomics
- Cancer PHGKB -
What's New
Last Posted: Oct 25, 2018
- Genetic profiling of melanoma in routine diagnostics: assay performance and molecular characteristics in a consecutive series of 274 cases.
Leichsenring Jonas et al. Pathology 2018 Oct - Circulating cell-free DNA- diagnostic and prognostic applications in personalized cancer therapy.
Oellerich M et al. Therapeutic drug monitoring 2018 Oct - Behavioral impact of return of genetic test results for complex disease: Systematic review and meta-analysis.
Frieser Maia J et al. Health psychology : official journal of the Division of Health Psychology, American Psychological Association 2018 Oct - A plasma microRNA biomarker of melanoma as a personalised assessment of treatment response.
van Laar Ryan K et al. Melanoma research 2018 Oct - Fast and Easy-to-Perform BRAF Testing in Melanoma Samples: An Accessible Tool for Pathologists With no Experience in Molecular Analyses.
Barel Fanny et al. Applied immunohistochemistry & molecular morphology : AIMM 2018 Oct - Cancer immunotherapy sweeps Nobel for medicine
J Kaiser et al, Science, October 4, 2018 - Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations.
Helgadottir Hildur et al. Journal of medical genetics 2018 Oct - CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients.
Dalmasso Bruna et al. Journal of the American Academy of Dermatology 2018 Sep - Systematic Review and Meta-analysis of the Prognostic Significance of miRNAs in Melanoma Patients.
Sabarimurugan Shanthi et al. Molecular diagnosis & therapy 2018 Sep - Treatment patterns and outcomes for patients with advanced melanoma in US oncology clinical practices.
Whitman Eric D et al. Future oncology (London, England) 2018 Sep
No hay comentarios:
Publicar un comentario